Skip to main content
Erschienen in: Medical Oncology 1/2013

01.03.2013 | Short Communication

Analysis on the correlation between number of lymph nodes examined and prognosis in patients with stage II colorectal cancer

verfasst von: Zhang Xingmao, Wang Hongying, Zhou Zhixiang, Wang Zheng

Erschienen in: Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Lymph nodes examined is important for N staging of colorectal cancer. There is no consensus on the optimal minimum number of lymph nodes for stage II colorectal cancer. This study was designed to determine the minimum number of lymph nodes and to identify the correlation between prognosis of stage II colorectal cancer and number of lymph nodes examined. Data of 729 patients with stage II colorectal cancer who underwent radical resection were studied retrospectively. The mean number of lymph nodes was 14.9 (range 1–58). Five-year survival rate was 76.8 %, and an average of 10.9 nodes was examined from deaths and 15.7 from survivors (P = 0.000). The difference of survival rates between patients with 13 or more nodes and less than 13 nodes was the most obvious (88.7 vs 64.9 %, P = 0.000). Thirteen was recommended as the minimum number of lymph nodes according to our results.
Literatur
1.
Zurück zum Zitat Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325–44.PubMedCrossRef Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325–44.PubMedCrossRef
2.
Zurück zum Zitat Peeples C, Shellnut J, Wasvary H, et al. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant? Dis Colon Rectum. 2010;53(11):1517–23.PubMedCrossRef Peeples C, Shellnut J, Wasvary H, et al. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant? Dis Colon Rectum. 2010;53(11):1517–23.PubMedCrossRef
3.
Zurück zum Zitat Shia J, Wang H, Nash GM, et al. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J Am Coll Surg. 2012;214(3):348–55.PubMedCrossRef Shia J, Wang H, Nash GM, et al. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J Am Coll Surg. 2012;214(3):348–55.PubMedCrossRef
4.
Zurück zum Zitat Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9.PubMedCrossRef Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912–9.PubMedCrossRef
5.
Zurück zum Zitat Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65–71.PubMedCrossRef Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65–71.PubMedCrossRef
6.
Zurück zum Zitat Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97(3):219–25.PubMedCrossRef Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97(3):219–25.PubMedCrossRef
7.
Zurück zum Zitat Kim YW, Kim NK, Min BS, et al. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg. 2009;249(6):965–72.PubMedCrossRef Kim YW, Kim NK, Min BS, et al. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg. 2009;249(6):965–72.PubMedCrossRef
8.
Zurück zum Zitat Wong JH, Severino R, Honnebier MB, et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896–900.PubMed Wong JH, Severino R, Honnebier MB, et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896–900.PubMed
9.
Zurück zum Zitat Kotake K, Honjo S, Sugihara K, et al. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol. 2012;42(1):29–35.PubMedCrossRef Kotake K, Honjo S, Sugihara K, et al. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol. 2012;42(1):29–35.PubMedCrossRef
10.
Zurück zum Zitat Yoshimatsu K, Ishibashi K, Umehara A, et al. How many lymph nodes should be examined in Dukes’ B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology. 2005;52(66):1703–6.PubMed Yoshimatsu K, Ishibashi K, Umehara A, et al. How many lymph nodes should be examined in Dukes’ B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology. 2005;52(66):1703–6.PubMed
11.
Zurück zum Zitat Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41(2):272–9.PubMedCrossRef Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41(2):272–9.PubMedCrossRef
12.
Zurück zum Zitat Choi HK, Law WL, Poon JT. The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer. 2010;10:267.PubMedCrossRef Choi HK, Law WL, Poon JT. The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer. 2010;10:267.PubMedCrossRef
Metadaten
Titel
Analysis on the correlation between number of lymph nodes examined and prognosis in patients with stage II colorectal cancer
verfasst von
Zhang Xingmao
Wang Hongying
Zhou Zhixiang
Wang Zheng
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2013
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-012-0371-0

Weitere Artikel der Ausgabe 1/2013

Medical Oncology 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.